通过比较分析F与A红系母细胞理解胎儿血红蛋白诱导的异质性
该研究开发技术从HUDEP2细胞系和原代红系培养中纯化分化阶段匹配的晚期F细胞和A细胞,进行转录和蛋白质组学分析。结果显示,在基线或羟基脲/泊马度胺处理后,F与A细胞在RNA水平差异极少,且未发现已知HbF调控因子(如BCL11A或LRF)的表达差异。结论提示F红系母细胞与非HbF表达细胞无显著差异,主要差异可能发生在β-珠蛋白基因座的转录水平。
要点
- F细胞与A细胞在RNA水平差异极小,即使经HbF诱导剂处理。
- 未发现BCL11A或LRF等已知调控因子的表达差异可解释HbF激活。
- HbF异质性可能源于β-珠蛋白基因座的转录水平差异。
核心结论
- F红系母细胞与非HbF表达细胞无显著差异,主要差异可能发生在β-珠蛋白基因座的转录水平。
研究设计与样本
- 研究开发了纯化分化阶段匹配的晚期红系母细胞F细胞和A细胞的技术,来源为人HUDEP2红系细胞系和原代人类红系培养。
- 对纯化的细胞进行了转录和蛋白质组学分析,比较基线及羟基脲或泊马度胺处理后的差异。
主要发现
- 在基线条件下或羟基脲/泊马度胺处理后,F与A细胞在RNA水平差异极少。
- 未发现已知HbF调控因子(包括BCL11A或LRF)的表达差异可解释HbF激活。
- 蛋白质组学分析显示F与A细胞间差异也很小。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Reversing the developmental switch from fetal hemoglobin (HbF, α2γ2) to adult hemoglobin (HbA, α2β2) is an important therapeutic approach in sickle cell disease (SCD) and β-thalassemia. In healthy individuals, SCD patients, and patients treated with pharmacologic HbF inducers, HbF is present only in a subset of red blood cells known as F cells. Despite more than 50 years of observations, the cause for this heterocellular HbF expression pattern, even among genetically identical cells, remains unknown. Adult F cells might represent a reversion of a given cell to a fetal-like epigenetic and transcriptional state. Alternatively, isolated transcriptional or posttranscriptional events at the γ-globin genes might underlie heterocellularity. Here, we set out to understand the heterogeneity of HbF activation by developing techniques to purify and profile differentiation stage-matched late erythroblast F cells and non-F cells (A cells) from the human HUDEP2 erythroid cell line and primary human erythroid cultures. Transcriptional and proteomic profiling of these cells demonstrated very few differences between F and A cells at the RNA level either under baseline conditions or after treatment with HbF inducers hydroxyurea or pomalidomide. Surprisingly, we did not find differences in expression of any known HbF regulators, including BCL11A or LRF, that would account for HbF activation. Our analysis shows that F erythroblasts are not significantly different from non-HbF-expressing cells and that the primary differences likely occur at the transcriptional level at the β-globin locus.
引用
- Khandros E, Huang P, Peslak SA, et al. Understanding heterogeneity of fetal hemoglobin induction through comparative analysis of F and A erythroblasts. Blood. 2020. PMID: 32268371. doi:10.1182/blood.2020005058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。